How much funding has GLO Pharma raised?

GLO Pharma has raised $22.0M in total funding, most recently a Series A round.

Who are GLO Pharma's investors?

GLO Pharma's investors include Lightspeed VP, First Round Capital.

When was GLO Pharma founded?

GLO Pharma was founded in 2018.

Where is GLO Pharma headquartered?

GLO Pharma is headquartered in United States.

What industry is GLO Pharma in?

GLO Pharma operates in Healthcare.

GLO Pharma

United States · Founded 2018 · $22.0M raised

Healthcare

Founded: 2018
Business Model: B2C
Total Funding: $22.0M

Last Round: $22.0M Series AAug 2021
Rounds: 1

About

GLO Pharma is a beauty and aesthetics company founded by Scott Glenn and Lauren Otsuki that develops next-generation skincare products for at-home use. Its flagship brand, Ourself, features the Subtopical Skincare System, a proprietary biotechnology platform designed to deliver clinical-level anti-aging results without an in-office procedure. Backed by Lightspeed Venture Partners since a 2020 Series A investment, GLO Pharma launched the Ourself product line in February 2022.

Summary

GLO Pharma is a Healthcare company based in United States, founded in 2018. It has raised $22.0M in total across 1 round, most recently a $22.0M Series A round in Aug 2021. Investors include Lightspeed VP and First Round Capital.